Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
FSG was reduced in SURPASS 15 between 43 and 63 mg/dL, and BW was reduced by between 5.4 to 11.7 kg in SURPASS 15
The American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk, or for those requiring additional glucose-lowering beyond metformin
on alternate days until there is no further improvement
Attenuation of prostaglandin E2 elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazole
US$ 20.38
US$ 27.81
US$ 20.37
US$ 28.48
US$ 26.95
US$ 22.44
